We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$19.6B
AUM Growth
-$1.06B
Cap. Flow
-$252M
Cap. Flow %
-1.29%
Top 10 Hldgs %
27.73%
Holding
2,867
New
60
Increased
922
Reduced
1,499
Closed
102

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$32.2M
2
NVDA icon
NVIDIA
NVDA
+$28.8M
3
SNV
Synovus
SNV
+$21M
4
AUB icon
Atlantic Union Bankshares
AUB
+$20.5M
5
MSFT icon
Microsoft
MSFT
+$20M

Sector Composition

Rank Sector Weight
1 Technology 28.46%
2 Financials 12.71%
3 Industrials 10.47%
4 Healthcare 10.16%
5 Consumer Discretionary 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SATL icon
2376
Satellogic
SATL
$523M
$144K ﹤0.01%
26,393
-25,467
-49% -$93.8K
MEC icon
2377
Mayville Engineering Co
MEC
$709M
$143K ﹤0.01%
7,958
EMN icon
2378
Eastman Chemical
EMN
$7.79B
$142K ﹤0.01%
1,858
-20
-1% -$1.44K
ATLO icon
2379
AMES National
ATLO
$271M
$142K ﹤0.01%
5,024
-133
-3% -$3.49K
KREF
2380
KKR Real Estate Finance Trust
KREF
$471M
$142K ﹤0.01%
23,155
-4,521
-16% -$33K
CRNC icon
2381
Cerence
CRNC
$368M
$141K ﹤0.01%
22,415
-776
-3% -$6.99K
RLGT icon
2382
Radiant Logistics
RLGT
$411M
$141K ﹤0.01%
20,057
+7,357
+58% +$51.6K
DNA icon
2383
Ginkgo Bioworks
DNA
$503M
$141K ﹤0.01%
22,948
+4,479
+24% +$37.3K
PINE
2384
Alpine Income Property Trust
PINE
$337M
$141K ﹤0.01%
7,811
-264
-3% -$4.9K
CAL icon
2385
Caleres
CAL
$447M
$140K ﹤0.01%
13,283
-3,939
-23% -$47K
FRHC icon
2386
Freedom Holding
FRHC
$9.84B
$140K ﹤0.01%
966
-46
-5% -$5.89K
LOAR icon
2387
Loar Holdings
LOAR
$6.7B
$140K ﹤0.01%
2,439
-117
-5% -$7.89K
NEXN
2388
Nexxen International
NEXN
$583M
$139K ﹤0.01%
21,392
HCKT icon
2389
Hackett Group
HCKT
$266M
$139K ﹤0.01%
10,706
-3,880
-27% -$62K
APPS icon
2390
Digital Turbine
APPS
$1.02B
$139K ﹤0.01%
48,327
-2,882
-6% -$12.4K
MNPR icon
2391
Monopar Therapeutics
MNPR
$731M
$139K ﹤0.01%
2,538
CLPT icon
2392
ClearPoint Neuro
CLPT
$436M
$139K ﹤0.01%
15,260
EVMN
2393
Evommune Inc
EVMN
$405M
$139K ﹤0.01%
+6,031
New +$136K
NMAX
2394
Newsmax Inc
NMAX
$1.03B
$138K ﹤0.01%
26,465
-788
-3% -$5.32K
CATX icon
2395
Perspective Therapeutics
CATX
$327M
$138K ﹤0.01%
33,079
+16,362
+98% +$69.1K
CFFI icon
2396
C&F Financial
CFFI
$271M
$138K ﹤0.01%
1,889
VEL icon
2397
Velocity Financial
VEL
$698M
$137K ﹤0.01%
7,564
FUNC icon
2398
First United
FUNC
$294M
$137K ﹤0.01%
3,733
UTMD icon
2399
Utah Medical Products
UTMD
$226M
$137K ﹤0.01%
2,202
LEGH icon
2400
Legacy Housing
LEGH
$639M
$136K ﹤0.01%
6,674

Similar funds

MetLife Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, MetLife Investment Management held 2,867 positions worth $19.6B, down 5.1% from $20.7B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

MetLife Investment Management's Q1 2026 filing shows 60 new, 922 increased, 1,499 reduced and 102 closed positions. Its largest new stake was State Street SPDR Portfolio High Yield Bond ETF: 1,674,673 shares worth $39.1M. The largest sale was Apple, an estimated $32.2M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.

  • MetLife Investment Management's largest Q1 2026 buy was State Street SPDR Portfolio High Yield Bond ETF: 1,674,673 shares worth $39.1M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $62.3M increase.
  • MetLife Investment Management's biggest Q1 2026 reduction was Apple, cutting an estimated $32.2M.
  • MetLife Investment Management fully exited Synovus in Q1 2026, selling an estimated $21M.
  • MetLife Investment Management's ten largest holdings make up 28% of its $19.6B portfolio in Q1 2026.
  • MetLife Investment Management opened 60 new positions and closed 102 in Q1 2026.
  • MetLife Investment Management's portfolio value fell 5.1% quarter-over-quarter to $19.6B.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.